Literature DB >> 18435436

Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities.

Renata Mikstacka1, Wanda Baer-Dubowska, Marcin Wieczorek, Stanislaw Sobiak.   

Abstract

Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural stilbene derivative occurring in grapes, peanuts and red wine. Its chemopreventive action has been established in studies on animal models. Recently, numerous classes of compounds with stilbene backbone have been investigated for their biological activity concerning cancer prevention; e. g. resveratrol methyl ethers appeared to be specific and potent inhibitors of cytochromes P450 (CYP) family 1 involved in the activation of procarcinogens. Since the replacement of the 4'-hydroxyl with a thiomethyl group is supposed to reduce toxicity of stilbene derivatives, the purpose of this study was the synthesis and evaluation of a series of 4-thiomethyl-trans-stilbene derivatives differing in a number and position of additional methoxy groups. Their inhibitory potency toward human recombinant CYPs: CYP1A1, CYP1A2 and CYP1B1 have been studied and compared with the effect of resveratrol and its analogues. Among compounds tested, 2-methoxy-4'-thiomethyl-trans-stilbene and 3-methoxy-4'-thiomethyl-trans-stilbene demonstrated the most potent and selective inhibitory effect on CYP1A1 and CYP1B1 activities. The results of our study indicate that modification of stilbene derivatives with thiomethyl group may influence the selectivity and inhibitory potency of these compounds toward P450 isozymes. Thus, it should be considered in developing new chemopreventive agents based on their mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435436     DOI: 10.1002/mnfr.200700202

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  14 in total

1.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

Review 2.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

3.  Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.

Authors:  Laura Macpherson; Jason Matthews
Journal:  Cancer Lett       Date:  2010-09-16       Impact factor: 8.679

4.  A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.

Authors:  Jiawang Liu; Peter T Pham; Elena V Skripnikova; Shilong Zheng; La'nese J Lovings; Yuji Wang; Navneet Goyal; Sydni M Bellow; Lydia M Mensah; Amari J Chatters; Melyssa R Bratton; Thomas E Wiese; Ming Zhao; Guangdi Wang; Maryam Foroozesh
Journal:  J Med Chem       Date:  2015-08-10       Impact factor: 7.446

5.  Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes.

Authors:  Sudheer R Beedanagari; Ilona Bebenek; Peter Bui; Oliver Hankinson
Journal:  Toxicol Sci       Date:  2009-04-17       Impact factor: 4.849

6.  Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug-metabolizing enzymes in rats fed a high-fat and high-sucrose diet.

Authors:  Junko Sugatani; Satoshi Sadamitsu; Tadashi Wada; Yasuhiro Yamazaki; Akira Ikari; Masao Miwa
Journal:  Nutr Metab (Lond)       Date:  2012-03-27       Impact factor: 4.169

7.  The effect of resveratrol and its methylthio-derivatives on EGFR and Stat3 activation in human HaCaT and A431 cells.

Authors:  Michal Cichocki; Hanna Szaefer; Violetta Krajka-Kuźniak; Wanda Baer-Dubowska
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

Review 8.  Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.

Authors:  K M Mair; A K Z Johansen; A F Wright; E Wallace; M R MacLean
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  Expression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell lines.

Authors:  Hanna Piotrowska; Malgorzata Kucinska; Marek Murias
Journal:  Mol Cell Biochem       Date:  2013-07-20       Impact factor: 3.396

Review 10.  Cytochrome P450 family 1 inhibitors and structure-activity relationships.

Authors:  Jiawang Liu; Jayalakshmi Sridhar; Maryam Foroozesh
Journal:  Molecules       Date:  2013-11-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.